TGTX — TG Therapeutics Inc

Ownership history in Campbell & CO Investment Adviser LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which Campbell & CO Investment Adviser LLC reported a position in TG Therapeutics Inc (TGTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.08% (2025 Q3)
Avg. % of fund
0.06%
First filed
2023 Q3
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 30,210 -9,417 -23.8% 0.08% $1.1M $36.12
2024 Q1 REDUCED 39,627 -3,520 -8.2% 0.05% $603K $15.21
2023 Q3 INITIATED 43,147 — — 0.04% $361K —
% of Fund (quarterly)    TGTX price (monthly, adj. close)

Other funds also holding TGTX

As of 2025 Q4 — sorted by position size

M28 Capital Management LP 3Y 3.5% Soleus Capital Management, L.P. 3Y 3.45% Opaleye Management Inc. 3Y 7Y 2.1% Pandora Wealth, Inc. 1.41% Penn Capital Management Company, LLC 3Y 7Y 1.28% Quantum Private Wealth, LLC 3Y 0.86% IRIDIAN ASSET MANAGEMENT LLC/CT 3Y 7Y 0.83% Knott David M Jr 3Y 0.62% nVerses Capital, LLC 0.56% Hood River Capital Management LLC 3Y 7Y 0.52%
← Back to Campbell & CO Investment Adviser LLC Holdings